Hollencrest Capital Management Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hollencrest Capital Management

  • $2.36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022
BUY
$83.14 - $145.99 $139,675 - $245,263
1,680 New
1,680 $245,000
Q1 2022

Apr 18, 2022
SELL
$110.08 - $142.92 $184,934 - $240,105
-1,680 Closed
0 $0
Q3 2021

Oct 13, 2021
BUY
$98.85 - $138.91 $166,068 - $233,368
1,680 New
1,680 $233,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email